Oxonian Ventures
VC Fund
San Francisco, United States
Oxonian Ventures is a VC fund in San Francisco focused on Software and Artificial Intelligence. Oxonian Ventures is the leading early-stage venture fund investing in Oxford alumni founded companies, using investment capital from Oxford alumni and affiliated institutions. Oxonian Ventures brings together Oxonian founders and investors to move ventures forward and elevate the visibility and reputation of Oxonian founded companies.
- Total investments:
- 33
- Last investment:
- Lead investor:
- 3%
Last updated:
For AI agents: llms.txt
Industries Oxonian Ventures invests in
Stages Oxonian Ventures invests in
Countries Oxonian Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Cameron Turner
|
|||
Delcho Ivanov
|
|||
| See all 8 contacts → | |||
Investment Focus
Industry
- Software 10 (30%)
- Artificial Intelligence 8 (24%)
- Biotechnology 6 (18%)
- Wellness 4 (12%)
- Health Care 4 (12%)
Stage
- Seed 15 (45%)
- Pre-Seed 9 (27%)
- Convertible Note 3 (9%)
- Series A 2 (6%)
- Angel 1 (3%)
Country
- United States 24 (73%)
- United Kingdom 5 (15%)
- Germany 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Rich Gill
Fund Manager
|
Fund Manager | Total investments: 1 | Find email | |
Austin Hwang
Venture Associate
|
Venture Associate | Total investments: 0 | Find email | |
|
Cameron Turner
Fund Manager
|
Fund Manager | Total investments: 3 | Find email | |
Charlie Cheesman
Vice President
|
Vice President | Total investments: 0 | Find email | |
|
Delcho Ivanov
Vice President
|
Vice President | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Valink Therapeutics
|
Valink Therapeutics is a health care drug discovery for next-generation cancer treatments. | $11.8M / Seed / Oct 20, 2025 | |
Motives AI
|
Motives AI operates AI agents that design, recruit, conduct, and analyze consumer interviews. | $500K / Pre-Seed / Sep 09, 2025 | |
Plexe AI
|
Plexe is a platform for creating ML models simply by describing problems in natural language. No ML expertise required. | $2.1M / Seed / Aug 25, 2025 | |
EVERBLOOM
|
Bloomlabs provides a method to catalyze waste value by regenerating it as adaptable and appealing bio-plastics and textile fibers. It envisions a future in which outmoded, resource-intensive processes are phased out in favor of cutting-edge, sustainable, and scalable alternatives. | $7.5M / Seed / Aug 19, 2025 | |
Parsewise
|
Automate data extraction, resolution, and validation from document packages to accelerate investment and underwriting workflows. Parsewise applies your decision criteria, completes custom templates, and delivers reliable insights – so your team acts faster with confidence. | $1.6M / Pre-Seed / Apr 16, 2025 | |
Conductor Quantum
|
Conductor Quantum is building quantum computers on silicon chips. Our AI-software creates qubits 1000x faster than current methods. | Pre-Seed / Oct 21, 2024 | |
Ligo Biosciences
|
Ligo Biosciences develops deep-learning models for enzyme design to reduce the cost of chemical manufacturing. | $500K / Pre-Seed / Sep 25, 2024 | |
Granza Bio
|
Granza Bio is a company that developing cancer therapies based on human body's immune system. | $7.1M / Seed / Jul 03, 2024 | |
Louisa AI
|
Louisa is a collective intelligence platform. The company's platform connects to a company's various data sources and auto-creates a comprehensive map of who and what everyone in the company knows. By providing employees with a centralized platform to access the collective intelligence of the company, Louisa is the one-stop shop for allyour knowledge and expertise needs. | $4.3M / Seed / Sep 01, 2023 | |
ExcepGen
|
ExcepGen is a venture-backed, early stage biotechnology company located in San Francisco. The company is focused on solving fundamental underlying problems in drug discovery and applying those solutions to create a new generation of therapeutics. | $4M / Seed / Aug 24, 2023 | |
| See all 33 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Oxonian Ventures invest in?
Oxonian Ventures invests primarily in Software, Artificial Intelligence and Biotechnology startups, most often at Seed and Pre-Seed stage. Most of the 33 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Oxonian Ventures?
Public channels for Oxonian Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Oxonian Ventures?
The team at Oxonian Ventures includes Rich Gill (Fund Manager), Austin Hwang (Venture Associate) and Cameron Turner (Fund Manager), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
